Tofacitinib reduced death or respiratory failure at 28 d in patients hospitalized with COVID-19 pneumonia.
Where this comes from
- Record sourced from PubMed, PMID 34606317.
- Also identified by DOI 10.7326/ACPJ202110190-111.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Guimarães PO, Quirk D, Furtado RH, et al. <b>Tofacitinib in patients hospitalized with Covid-19 pneumonia.</b> N Engl J Med. 2021;385:406-15. 34133856.
Medical subject headings
- COVID-19
- Respiratory Insufficiency